Although the detail molecular mechanisms for individual expression of EIF3C in tumor progression of HCC and other cancer types remain obscure, upregulated-EIF3C served as theranostic marker through treatment of exosome generation inhibitor GW4869 and suppression of S100A11 expression is firmly established. Here, S100A11 is linked to cancer.